R. Zheng, “MAL, a potential immunotherapy target, is associated with poor prognosis in cancer patients: A pan-cancer study of MAL”, Cell Mol Biol (Noisy-le-grand), vol. 70, no. 4, pp. 248–254, Apr. 2024.